Sunday, July 12, 2026
News

NPPA fixes retail prices of 39 new drug formulations

SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | July 11, 2026 11:27:11 AM IST
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 39 new drug formulations under the Drugs (Prices Control) Order (DPCO), 2013.

The formulations cover a wide range of medicines, including those used to treat hypertension, diabetes, HIV, heart disease and eye infections, with the aim of making them more affordable for patients.

The notification was issued on July 8. It is a retail price fixation order for new drug formulations under the DPCO, 2013, and not a price reduction order.

Among the medicines included, Amlodipine + Bisoprolol + Telmisartan Tablets, used for the treatment of hypertension (high blood pressure), have been fixed at Rs 14.74 per tablet.

The retail price of Nepafenac + Moxifloxacin Ophthalmic Solution, an eye drop used after eye surgery and for the treatment of bacterial eye infections, has been fixed at Rs 68.64 per ml.

Similarly, Clopidogrel + Aspirin + Atorvastatin Capsules, which are used to reduce the risk of heart attack and stroke, have been priced at Rs 6.37 per capsule.

The NPPA also reiterated that retailers and dealers are required to prominently display the price lists provided by manufacturers.

Quoting the DPCO, 2013, the authority said, "As per para 24(4) of DPCO, 2013, every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same."

The notification further stated that if any manufacturer or marketing company fails to comply with the notified retail prices, it will be liable to deposit the overcharged amount along with applicable interest.

"In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955," the notification stated. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
'Systematic loot in front of CCTV camera...
CM Yogi Adityanath to launch 'Maha Vriks...
Keralam Minister Bindu Krishna visits fa...
'Narottam was big challenge, people neve...
Moshi building collapse tragedy: Death t...
Moshi building collapse: Deputy CM Sunet...
More...    
 
 Top Stories
FIFA World Cup 2026: "We gave every... 
Iran, Oman hold talks in Muscat, di... 
Fire breaks out in house at Delhi's... 
England crush India by 56 runs to s... 
Anjum Chopra inducted into ICC Cric... 
Former England cricketer Kevin Piet... 
Chinese envoy backs stronger India-... 
Pradhanmantri Sangrahalaya launches...